Valuation (14%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -7.28 | N/A |
PEG Ratio (TTM) | -0.07 | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | 0.97 | N/A |
P/FCF Ratio (TTM) | -8.21 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -12.54% | N/A |
ROE (TTM) | -12.86% | N/A |
Net Profit Margin (TTM) | N/A | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 22.39% | 135.07% | N/A |
Revenue | N/A | N/A | N/A |
Net Income | 23.37% | -326,177.79% | N/A |
Cash Flow | -5.40% | -1,030,865.00% | N/A |
Health (58%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 18.78 | N/A |
Quick Ratio (TTM) | 18.78 | N/A |
D/E Ratio (TTM) | 0.00 | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 1 | N/A |
Altman Z-Score | 9.61 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |